The highest estimate is 44.00. From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
The current price of ODTX is $19.54 USD — it has decreased by -1.46% in the past 24 hours. Watch Odyssey Therapeutics stock price performance more closely on the chart.
What is Odyssey Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Odyssey Therapeutics stocks are traded under the ticker ODTX.
What is Odyssey Therapeutics market cap?▼
Today Odyssey Therapeutics has the market capitalization of 939.06M
When is the next Odyssey Therapeutics earnings date?▼
Odyssey Therapeutics is going to release the next earnings report on December 2, 2026.
What were Odyssey Therapeutics earnings last quarter?▼
ODTX earnings for the last quarter are -1.74 USD per share, whereas the estimation was -1.61 USD resulting in a -7.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Odyssey Therapeutics revenue for the last year?▼
Odyssey Therapeutics revenue for the last year amounts to 2.98M USD.
What is Odyssey Therapeutics net income for the last year?▼
ODTX net income for the last year is -148.65M USD.
How many employees does Odyssey Therapeutics have?▼
As of November 2, 2026, the company has 100 employees.
In which sector is Odyssey Therapeutics located?▼
Odyssey Therapeutics operates in the Health & Wellness sector.
When did Odyssey Therapeutics complete a stock split?▼
Odyssey Therapeutics has not had any recent stock splits.
Where is Odyssey Therapeutics headquartered?▼
Odyssey Therapeutics is headquartered in BOSTON, United States.